Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Balance Sheet

230 Followers

Keros Therapeutics Balance Sheet

Keros Therapeutics's total assets for Q2 2024 were $455.02M, a decrease of -6.34% from the previous quarter. KROS total liabilities were $34.11M for the fiscal quarter, a 7.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 370.02M$ 306.78M$ 255.25M$ 269.44M$ 10.96M
Total Liabilities
$ 37.81M$ 29.36M$ 12.08M$ 7.72M$ 10.46M
Total Equity Gross Minority
$ 332.21M$ 277.42M$ 243.17M$ 261.72M$ 495.00K
Total Capitalization
$ 345.65M$ 290.23M$ 243.41M$ 262.20M$ 495.00K
Preferred Stock Equity
----$ 19.94M
Capital Lease Obligations
----$ 1.27M
Currency in USD

Keros Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis